Cargando…
Differences in oestrogen receptors in malignant and normal breast tissue as identified by the binding of a new synthetic progestogen.
Oestrogen receptor protein (ER) was detected in 9 of 11 samples of malignant breast tissue and 8 of 9 samples of normal breast tissue. Levels of cytosolic ER (ERc) in malignant breast were 21-1102 fmol mg-1 soluble protein (Kd 1.8 X 10(-9)-3.1 X 10(-8) mol l-1) and those of nucleosolic ER (ERn), 13-...
Autores principales: | Iqbal, M. J., Colletta, A. A., Houmayoun-Valyani, S. D., Baum, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001611/ https://www.ncbi.nlm.nih.gov/pubmed/3756080 |
Ejemplares similares
-
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
por: van Hylckama Vlieg, A, et al.
Publicado: (2009) -
Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022) -
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
por: Garcia-Albeniz, Xabier, et al.
Publicado: (2016) -
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
por: Lidegaard, Øjvind, et al.
Publicado: (2011) -
Progestogens in menopausal hormone therapy
por: Bińkowska, Małgorzata, et al.
Publicado: (2015)